End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.48 CNY | +1.15% |
|
+0.18% | +12.77% |
Jun. 14 | Second Chinese drugmaker seeks approval for Ozempic generic | RE |
Jun. 13 | Sihuan Pharma Subsidiary Licenses Fadanafil Drug to Livzon Pharmaceutical Unit | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.77% | 4.42B | |
+41.57% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.47% | 246B | |
+0.12% | 225B | |
+10.40% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Provides Earnings Guidance for the Half Year Ended June 30, 2016